Black Women Have 41% Higher Risk of Dying of Breast Cancer

Black women are dying of breast cancer at a much more aggressive rate than white women—and a new study finds that disparities in healthcare are to blame.

A study from the Centers for Disease Control (CDC) shows that while white women have a higher incidence of breast cancer, Black women have a 41 percent higher mortality rate—perhaps because more Black women are diagnosed with regional- or distant-stage cancer (45 percent versus 35 percent). Out of every 100 breast-cancer diagnoses, Black women have nine more deaths (27 versus 18).

“Breast-cancer death rates have been declining among U.S. women since 1990 because of early detection and advances in treatment; however, all racial groups have not benefited equally,” reads the report. “Black women experience inequities in breast-cancer screening, follow-up, and treatment after diagnosis, leading to greater mortality.”

Black women’s diagnosis-to-mammogram intervals are longer than white women, even when both individuals have the same insurance—20 percent of Black women had an interval of 60 days or more compared with 12 percent of white women.

One study showed that equitable treatment could eliminate up to 19 percent of the mortality difference between Black and white women.

Eliminating Racial Disparities in Healthcare

“It’s a complex problem, but there are clearly avoidable components of this that we can address and resolve—the issues related to healthcare quality,” Dr. Marcus Plescia, Director of the Division of Cancer Prevention and Control at the CDC and one of the report’s authors, told The New York Times. “It’s time to step forward and say that this disparity is unacceptable.”

“Many studies have shown that there is a direct correlation between people of diverse backgrounds being willing to seek care and knowing that people who look like them will actually be providing that care. So the intersection between diversity and disparities is rather significant,” explains Zenty in the video below. “We want to make certain that we’re doing everything that we can to make sure that people of color will be able to work in our organization, hold positions of leadership—caregivers, clinicians and support staff.” Read this Q&A with University Hospitals CEO Thomas Zenty for more.

“The importance of diversity as an underpinning of our business success today and for the future has become more clear to me and more evident,” he says. “Our business is shifting in terms of serving different populations and different segments of different populations, both here in the U.S. and in emerging markets. It’s brought me and the whole company a greater awareness of how different we are with respect to the way in which medicine is practiced, the way in which treatment is sought, the way in which people understand disease and approach therapy.” Read this Q&A with Eli Lilly CEO John Lechleiter for more. Eli Lilly and Company is No. 29 in the DiversityInc Top 50.